Appears some people have noticed the CDC‘s recommendation for urine drug testing in pain management have nothing to with helping with patient care and could be a profit driven motive to drug testing patients in pain, and physicians‘ fears and inability to effectively treat pain.
The annual cost of drug testing in pain management is estimated at $2 billion per year. Unfortunately, that may be a gross underestimate since no study has ever evaluated the indirect costs of patient harm or harming the therapeutic patient-provider relationship—likely the most important aspect of pain management. A November, 2014 article in the Wall Street Journal reported that some physicians are making more money from drug testing patients than treating them.
source: http://www.painnewsnetwork.org/stories/2016/1/5/the-cdc-and-profit-driven-drug-testing